Literature DB >> 12527224

Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers.

Maria Kantzanou1, Michaela Lucas, Eleanor Barnes, Harvki Komatsu, Geoff Dusheiko, Scott Ward, Gillian Harcourt, Paul Klenerman.   

Abstract

Hepatitis C virus (HCV) has infected over 170 million people world wide, and in the majority sets up a chronic infection associated with hepatic inflammation. How it evades host immunity, particularly CD8+ T cells (CTL) is unclear, but two major factors are likely to operate, viral escape mutation and T cell exhaustion. We have investigated the role of CTL in control of infection during acute disease using Class I peptide tetramers. Although the immune response is quite diverse and numerous epitopes can be targeted, we observe that, especially during acute disease, one epitope (NS3 1073-81) is commonly recognised in HLA-A2 positive individuals. However, the levels of response to this epitope (and others) are very much lower if persistence is established. We examined in detail whether the cause of this low level of reactivity is due to mutation within the epitope. We find that, in fact this epitope is highly conserved during chronic infection, at a clonal level, between individuals, and over time. Thus, although variation within the epitope does occur, lack of reactivity in peripheral blood against this epitope in chronic disease, and loss of control of virus cannot be explained entirely by viral escape. Escape through mutation probably does play an important role in persistence of HCV, but we also discuss other mechanisms which lead to attenuation of T cell responses which may be important in determining the outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527224     DOI: 10.1016/s0165-2478(02)00224-9

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  19 in total

1.  Contributions of the viral genetic background and a single amino acid substitution in an immunodominant CD8+ T-cell epitope to murine coronavirus neurovirulence.

Authors:  Katherine C MacNamara; Ming Ming Chua; Joanna J Phillips; Susan R Weiss
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses.

Authors:  Nadia Alatrakchi; Camilla S Graham; Hans J J van der Vliet; Kenneth E Sherman; Mark A Exley; Margaret James Koziel
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

3.  Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2.

Authors:  Shanmugalakshmi Sadagopal; Rama Rao Amara; David C Montefiori; Linda S Wyatt; Silvija I Staprans; Natalia L Kozyr; Harold M McClure; Bernard Moss; Harriet L Robinson
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury.

Authors:  Jiaren Sun; Batbayar Tumurbaatar; Junhui Jia; Hong Diao; Francis Bodola; Stanley M Lemon; Wendell Tang; David G Bowen; Geoffrey W McCaughan; Patrick Bertolino; Teh-Sheng Chan
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication.

Authors:  Gennadiy Zelinskyy; Lara Myers; Kirsten K Dietze; Kathrin Gibbert; Michael Roggendorf; Jia Liu; Mengji Lu; Anke R Kraft; Volker Teichgräber; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

Review 6.  Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection.

Authors:  Meenakshi Sachdeva; Yogesh K Chawla; Sunil K Arora
Journal:  World J Hepatol       Date:  2015-09-08

7.  Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance.

Authors:  Gerald Willimsky; Karin Schmidt; Christoph Loddenkemper; Johanna Gellermann; Thomas Blankenstein
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

8.  Cross-genotype immunity to hepatitis C virus.

Authors:  Robert E Lanford; Bernadette Guerra; Deborah Chavez; Catherine Bigger; Kathleen M Brasky; Xiao-Hong Wang; Stuart C Ray; David L Thomas
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Underwhelming the immune response: effect of slow virus growth on CD8+-T-lymphocyte responses.

Authors:  Gennady Bocharov; Burkhard Ludewig; Antonio Bertoletti; Paul Klenerman; Tobias Junt; Philippe Krebs; Tatyana Luzyanina; Cristophe Fraser; Roy M Anderson
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 10.  Liver immunology.

Authors:  Dimitrios P Bogdanos; Bin Gao; M Eric Gershwin
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.